PLG peptidomimetics

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NamePLG peptidomimetics
Drug Alias NameN/A
ClassificationSmall molecules > Peptidomimetic
Mechanisms of ActionDopamine D2 receptor modulators
TargetsDopamine D2 receptor
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Minnesota
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Minnesota
Active IndicationsN/A
Inactive IndicationsParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A